<?xml version="1.0" encoding="UTF-8"?>
<p>As of now, no effective therapy has been introduced for COVID-19. Some anti-inflammatory agents and cytokine release inhibitors, like corticosteroids and tocilizumab (acting against IL-6), have been proposed (
 <xref rid="B17" ref-type="bibr">17</xref>, 
 <xref rid="B18" ref-type="bibr">18</xref>). However, increasing risk of secondary infections, activation of latent tuberculosis, and other adverse effects are serious concerns (
 <xref rid="B19" ref-type="bibr">19</xref>). Lopinavir-ritonavir did not improve time to the clinical improvement and mortality (
 <xref rid="B5" ref-type="bibr">5</xref>). The efficacy of other therapeutic modalities, like convalescent plasma, is not clear (
 <xref rid="B20" ref-type="bibr">20</xref>).
</p>
